ArticleScientific reports2017

Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer.

Yi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.